Vaxart, Inc. Increase (Decrease) in Other Accrued Liabilities
Vaxart, Inc. (VXRT) reported Increase (Decrease) in Other Accrued Liabilities of -$1.51 million for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccruedLiabilities · last filed 2020-11-12
- Vaxart, Inc. increase (decrease) in other accrued liabilities for the quarter ending 2020-09-30 was -$2.89M.
- Vaxart, Inc. increase (decrease) in other accrued liabilities for the quarter ending 2020-06-30 was $1.90M.
- Vaxart, Inc. increase (decrease) in other accrued liabilities for the quarter ending 2020-03-31 was -$520.00K, a 625.25% decline year-over-year.
- Vaxart, Inc. increase (decrease) in other accrued liabilities for the quarter ending 2019-09-30 was -$78.00K.
| Period end | Increase (Decrease) in Other Accrued Liabilities 3 month | Increase (Decrease) in Other Accrued Liabilities 6 month | Increase (Decrease) in Other Accrued Liabilities 9 month |
|---|---|---|---|
| 2020-09-30 | -$2.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$991.00K derived: sum of 2 quarters · filed 2020-11-12 | -$1.51M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $1.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $1.38M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | -$520.00K 10-Q · filed 2020-05-12 | ||
| 2019-09-30 | -$78.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$548.00K derived: sum of 2 quarters · filed 2020-11-12 | -$449.00K 10-Q · filed 2020-11-12 |
| 2019-06-30 | -$470.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$371.00K 10-Q · filed 2020-08-06 | |
| 2019-03-31 | $99.00K 10-Q · filed 2020-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |